CTRI/2018/05/013757招募中未知
eoadjuvant Chemotherapy vs Neoadjuvant Chemoradiotherapy for Resectable Carcinoma Gastroesophageal junction : a Randomized Controlled Trial
Dr Shivendra Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with resectable and hitologically proven adenocarcinoma of Gastroesophageal junction(type I,II,III) who are fit for surgery(ECOG performance status 0,1,2); No Distant metastasis on PET scan and Staging Laparoscopy
排除标准
- •Distant metastasis on Staging Laparoscopy or on PET scan; refusal for informed consent for procedure; locally unresectable tumors; tumors falling in stage cT1N0 on Endoscopic ultrasound examination
研究者
相似试验
尚未招募
3 期
Phase 3 comparative study of two treatment arms in case of operable carcinoma esophagusCTRI/2024/02/062497TMH TRAC
尚未招募
不适用
eoadjuvant chemoradiotherapy vs. chemotherapy alone in locally advanced esophageal squamous cell carcinoma: randomized phase II studyNeoplasmsKCT0002181Seoul National University Hospital114
招募中
不适用
Therapy used for Carcinoma Gallbladder after SurgeryCTRI/2018/01/011296Dr Shivendra Singh
尚未招募
2 期
Comparison of chemotherapy before and after definitive chemotherapy-radiotherapy with definitive chemotherapy-radiotherapy alone in patients with advanced cervical cancerIRCT20211011052730N1Shahid Beheshti University of Medical Sciences35
进行中（未招募）
1 期
eoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancerColon cancerMedDRA version: 19.0Level: LLTClassification code 10009951Term: Colon cancer NOSSystem Organ Class: 100000004864EUCTR2013-002363-26-SEVejle Hospital250